Optimal formula of urinastatin vaginal suppository and it’s clinical usefulness

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: SATAKE, Kiyoshi (Saitama Redcloss Hospital, Hospital, saitamasi, Japan)
  • Co-author(s): Kiyoshi Satake: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Hideaki Monchusho: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Takanori Nakajima: Department of Clinical Pharmaceutics, Nihon Pharmaceutical University, saitama, Japan
    Masanori Iwata: Department of Clinical Pharmaceutics, Nihon Pharmaceutical University, saitama, Japan
    Mitsuru Machida: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Sumitaka Miyamoto: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
    Manabu Nakamura: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
    Akihiko Ando: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
  • Abstract:

    Methods

     (1) Preparation: An optimal prescription was examined based on the type of cardinal drug (freeze-dry type or aqueous type injection) and physicochemical properties of the base. (2) Usages: A questionnaire survey involving Japanese Red Cross hospitals was conducted. (3) Clinical Usefulness: The prolongation of the pregnancy period, the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login